On April 8, 2021 Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, reported that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, will participate in Canaccord Genuity’s 2021 Horizons in Oncology Virtual Conference (Press release, Aptose Biosciences, APR 8, 2021, View Source [SID1234577723]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Canaccord Genuity’s 2021 Horizons in Oncology Virtual Conference

Panel: Opportunities in BPDCN and AML
Date: Thursday, April 15, 2021
Time: 3:00 – 3:55 PM EDT
Format: Panel Moderated by John Newman, Ph.D., Managing Director, Biotechnology Analyst

Conference Information: Link
The Aptose management team also will be hosting 1×1 meetings during the event.